Literature DB >> 15802864

Real-time imaging of hypoxia-inducible factor-1 activity in tumor xenografts.

Junye Liu1, Runjiang Qu, Masakazu Ogura, Toru Shibata, Hiroshi Harada, Masahiro Hiraoka.   

Abstract

Hypoxia-inducible factor-1 (HIF-1) is responsible for various gene expressions related to tumor malignancy, such as metastasis, invasion and angiogenesis. Therefore, monitoring HIF-1 activity in solid tumors is becoming increasingly important in clinical and basic studies. To establish a convenient system for visualizing HIF-1 activity in tumor xenografts, we employed a promoter consisting of five copies of hypoxia response elements (5HRE), whose activity depends on HIF-1, and used a derivative of green fluorescence protein (d2EGFP) as a reporter gene. A human melanoma cell line, Be11, which contains the 5HRE-d2EGFP gene, showed fluorescence in response to hypoxia. The fluorescent intensity correlated inversely with the surrounding oxygen tension, and was time-dependent for the hypoxic treatment. Reoxygenation resulted in a rapid decrease in fluorescence due to the signal sequence for protein degradation encoded in d2EGFP, which enabled monitoring of HIF-1 activity in real-time. Heterogeneous fluorescence was observed in the solid tumor of a non-sacrificed tumor-bearing mouse. Immunohistochemical analysis confirmed that d2EGFP-expressing regions overlapped with the ones stained with a hypoxia marker, pimonidazole. These results suggest that the 5HRE-d2EGFP gene is suitable for the real-time imaging of HIF-1-activating cells in vivo, due to the short half-life of the d2EGFP protein as well as the specificity of the 5HRE promoter for HIF-1 activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15802864     DOI: 10.1269/jrr.46.93

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  14 in total

Review 1.  Gene expression and gene therapy imaging.

Authors:  Claire Rome; Franck Couillaud; Chrit T W Moonen
Journal:  Eur Radiol       Date:  2006-09-12       Impact factor: 5.315

2.  Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2α and survival.

Authors:  Alexandra Giatromanolaki; Efthimios Sivridis; Nikolaos E Bechrakis; Gregor Willerding; Georgios St Charitoudis; Michael H Foerster; Kevin C Gatter; Adrian L Harris; Michael I Koukourakis
Journal:  Clin Exp Metastasis       Date:  2011-10-09       Impact factor: 5.150

3.  Direct visualization of the phenotype of hypoxic tumor cells at single cell resolution in vivo using a new hypoxia probe.

Authors:  Yarong Wang; Haoxuan Wang; Jiufeng Li; David Entenberg; Alice Xue; Weigang Wang; John Condeelis
Journal:  Intravital       Date:  2016-05-16

4.  Anti-vascular endothelial growth factor antibody single therapy for pancreatic neuroendocrine carcinoma exhibits a marked tumor growth-inhibitory effect.

Authors:  Kazuhiko Kasuya; Yuichi Nagakawa; Minako Suzuki; Hiroaki Tanaka; Hiroshi Ohta; Takao Itoi; Akihiko Tsuchida
Journal:  Exp Ther Med       Date:  2011-09-05       Impact factor: 2.447

5.  Expression of hypoxia-inducible factor-1alpha in liver tumors after transcatheter arterial embolization in an animal model.

Authors:  Bin Liang; Chuansheng Zheng; Gansheng Feng; Yong Wang; Hui Zhao; Huimin Liang; Enhua Xiao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-12-29

6.  Imaging and Targeting of the Hypoxia-inducible Factor 1-active Microenvironment.

Authors:  Shinae Kizaka-Kondoh; Shotaro Tanaka; Masahiro Hiraoka
Journal:  J Toxicol Pathol       Date:  2009-07-07       Impact factor: 1.628

7.  Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels.

Authors:  Hiroshi Harada; Masahiro Inoue; Satoshi Itasaka; Kiichi Hirota; Akiyo Morinibu; Kazumi Shinomiya; Lihua Zeng; Guangfei Ou; Yuxi Zhu; Michio Yoshimura; W Gillies McKenna; Ruth J Muschel; Masahiro Hiraoka
Journal:  Nat Commun       Date:  2012-04-17       Impact factor: 14.919

8.  Real-time visualization of human prolactin alternate promoter usage in vivo using a double-transgenic rat model.

Authors:  Sabrina Semprini; Sonke Friedrichsen; Claire V Harper; Judith R McNeilly; Antony D Adamson; David G Spiller; Nina Kotelevtseva; Gillian Brooker; David G Brownstein; Alan S McNeilly; Michael R H White; Julian R E Davis; John J Mullins
Journal:  Mol Endocrinol       Date:  2009-01-15

9.  Treatment regimen determines whether an HIF-1 inhibitor enhances or inhibits the effect of radiation therapy.

Authors:  H Harada; S Itasaka; Y Zhu; L Zeng; X Xie; A Morinibu; K Shinomiya; M Hiraoka
Journal:  Br J Cancer       Date:  2009-02-17       Impact factor: 7.640

10.  Adenovirus-mediated hypoxia-targeting cytosine deaminase gene therapy enhances radiotherapy in tumour xenografts.

Authors:  J Liu; H Harada; M Ogura; T Shibata; M Hiraoka
Journal:  Br J Cancer       Date:  2007-05-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.